Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market
Drug Topics
NOVEMBER 28, 2024
Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.
Thu.Nov 28, 2024
494 
Advancing Vaccine Development for RSV and hMPV: Overcoming Challenges With Pre-Fusion F Protein Stability
Pharmacy Times
NOVEMBER 28, 2024
Researchers developed a method to stabilize respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) fusion (F) proteins, advancing potential vaccines for both viruses.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Diabetes Roundup: Depression Increases Risk, Key Things to Know about Insulin Icodec
Drug Topics
NOVEMBER 28, 2024
Catch up on important diabetes news from November 2024.
Recent Intravenous Immunoglobulin Administration Can Lead to Serum Protein Electrophoresis Misdiagnosis
Pharmacy Times
NOVEMBER 28, 2024
Knowledge of recent intravenous immunoglobulin (IVIG) administration in patients receiving the common laboratory test can help inform misdiagnosis.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA probing cancer cases with Bluebird's CALD gene therapy
pharmaphorum
NOVEMBER 28, 2024
The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's Skysona gene therapy for neurological disease CALD.
Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat
Pharmaceutical Technology
NOVEMBER 28, 2024
The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
Pharmaceutical Technology
NOVEMBER 28, 2024
There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.
Designing personalised digital experiences that engage healthcare professionals
pharmaphorum
NOVEMBER 28, 2024
Designing personalised digital experiences for healthcare professionals (HCPs) involves collaboration between digital designers and data experts. Learn how to engage HCPs effectively with tailored digital solutions.
Understanding the Risks of Polypharmacy
Pharmacy Times
NOVEMBER 28, 2024
Using multiple physicians or pharmacists can result in a lack of coordinated care, missed medication interactions, and overlooked contraindications.
Neuralink unveils trial linking brain implant to robotic arm
pharmaphorum
NOVEMBER 28, 2024
Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fun Fact: A Chemical Found in Turkey Might Contribute to Post-Thanksgiving Drowsiness
Pharmacy Times
NOVEMBER 28, 2024
Tryptophan, found in turkey and other foods, affects serotonin and melatonin production.
Applied Tx craters as FDA rejects lead product candidate
pharmaphorum
NOVEMBER 28, 2024
Applied Therapeutics plummets after the FDA turns down its marketing application for govorestat as a treatment for galactosaemia
How AI and Data Analytics Are Transforming the PBM Industry: A Look at Predictive Modeling, Risk Stratification, and Personalized Care
Pharmacy Times
NOVEMBER 28, 2024
Rising health care costs and the complex nature of medication management have prompted PBMs to adopt AI tools to enhance patient outcomes, streamline claims processes, reduce waste, and design smarter, data-driven health plans.
Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition
Pharmaceutical Technology
NOVEMBER 28, 2024
The relationship between climate change and infectious disease is raising new questions for pharmaceutical and clinical leaders.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
UK grants promising innovative medicine status to CIDP drug
Pharma Times
NOVEMBER 28, 2024
Therapy for autoimmune disorder shows potential
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Pharmaceutical Technology
NOVEMBER 28, 2024
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).
Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more
Pharmaceutical Commerce
NOVEMBER 28, 2024
The latest news for pharma industry insiders.
Kronos Bio announces interim CEO and workforce cuts of 83%
Pharmaceutical Technology
NOVEMBER 28, 2024
Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective 3 December.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more
PharmExec
NOVEMBER 28, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advanz Pharma’s liver disease drug pulled from European market after court hearing
Pharmaceutical Technology
NOVEMBER 28, 2024
This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024.
LEAP HR: Life Sciences West
pharmaphorum
NOVEMBER 28, 2024
Join us in San Francisco, CA this April for LEAP HR: Life Sciences West to network with 200+ senior HR leaders
EC approves GSK’s Menveo vaccine presentation for IMD
Pharmaceutical Technology
NOVEMBER 28, 2024
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
New injection offers hope for asthma and COPD attacks
Pharma Times
NOVEMBER 28, 2024
Injection significantly reduces need for further treatment
Study finds AZ's benralizumab a 'game-changer' in asthma
pharmaphorum
NOVEMBER 28, 2024
Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks
The EU AI Act: will regulation drive life science innovation away from Europe?
European Pharmaceutical Review
NOVEMBER 28, 2024
When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity. As the EU now sets its sights on the regulation of artificial intelligence (AI) through the EU Artificial Intelligence Act (EU AI Act), 2 similar questions arise regarding the implementation and enforcement of the regulation.
Final joint guidance on chronic asthma overhauls pharmacological recommendations
Hospital Pharmacy Europe
NOVEMBER 28, 2024
Long-awaited joint UK guidelines for chronic asthma have been finalised, overhauling diagnosis and treatment recommendations in an effort to better manage the condition in primary care and reduce pressure on hospitals. The final chronic asthma guidance from the National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN) is designed to support clinicians in making accurate diagnoses, promoting good practice, a
Trump agency nominations show pharma industry as divided as US
Pharmaceutical Technology
NOVEMBER 28, 2024
Confirmation of Trump's nominations for appointments is not yet assured and the Senate will vote to approve them early in 2025.
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Pharmaceutical Technology
NOVEMBER 28, 2024
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
Let's personalize your content